-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Aveo Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2021.
- Aveo Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$1.1M, a 4.77% increase year-over-year.
- Aveo Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$4.55M, a 203% decline year-over-year.
- Aveo Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$3.79M, a 215% decline from 2020.
- Aveo Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2020 was $3.29M, a 66.3% decline from 2019.
- Aveo Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2019 was $9.76M, a 51.3% decline from 2018.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)